Den Hollander, D., et al. “Predictive Factors for Toxicity and Survival of Second-Line Sunitinib in Advanced Gastrointestinal Stromal Tumours (GIST)”. Acta Oncologica, vol. 58, no. 11, Nov. 2019, pp. 1648-54, doi:10.1080/0284186X.2019.1637017.